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Abstract
Objectives: This systematic review evaluated the evidence on the effect of the inter-
ventions aimed for lateral ridge augmentation (both simultaneously with implant 
placement or as a staged procedure) on peri- implant health or disease.
Methods: A protocol was developed to answer the following PICO question: “In pa-
tients with horizontal alveolar ridge deficiencies (population), what is the effect of 
lateral bone augmentation procedures (intervention and comparison) on peri- implant 
health (outcome)?” Included studies were randomised controlled trials or controlled 
clinical trials with a follow- up of at least 12 months after implant loading. Meta- 
analyses were performed whenever possible, including subgroup analysis based on 
follow- up.
Results: Twelve final publications from eight investigations were included. The results 
from the meta- analysis indicated that irrespective of the type of intervention, the in-
flammatory changes, based on bleeding on probing (%) were minimal, both at short- 
(n = 1; weighted mean difference [WMD] = −1.00; 95% CI [−14.04; 12.04]; p = .881) 
and long- term (n = 5; WMD = −5.63; 95% CI [−18.42; 7.16]; p = .881). When compar-
ing different treatment modalities, no significant differences were observed (n = 6; 
WMD = −3.36; 95% CI [−12.49; 5.77]; p < .471). Similarly, changes in probing pocket 
depth and marginal bone levels were not significantly different among groups. The 
incidence of peri- implantitis was evaluated in three investigations and varied from 
16% to 26% after a follow- up period of 6–8 years.
Conclusions: The results from this systematic review and meta- analysis have shown 
that lateral ridge augmentation procedures can maintain peri- implant health over time 
with low mucosal inflammatory changes and a relatively small incidence of peri- implant 
bone loss.
K E Y W O R D S
alveolar ridge atrophy, bone regeneration, bone substitutes, dental implant, periodontal index, 
ridge augmentation
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1  | INTRODUCTION
Dental implants have become a highly predictable treatment to re-
habilitate, partially or fully, edentulous patients, with resulting cu-
mulative survival rates ranging between 89.5% and 92.7% after 
10–27 years of function (Balshi, Wolfinger, Stein, & Balshi, 2015; 
Chappuis et al., 2013). However, due to the bone resorptive changes 
occurring in the alveolar process after tooth extraction (Schropp, 
Wenzel, Kostopoulos, & Karring, 2003; Vignoletti et al., 2012) or 
due to pathologic bone loss, as a result of periodontitis, trauma or 
infection, it is frequently the lack of sufficient bone volume to place 
implants in the ideal prosthetic position, which is a critical factor 
to attain the appropriate function and aesthetics of the implant- 
supported restorations.
To reconstruct deficient alveolar ridges to facilitate dental im-
plant placement different bone regenerative techniques have been 
proposed and evaluated (Donos et al., 2008; Rocchietta, Fontana, 
& Simion, 2008). Depending on the morphology of the bone de-
fect (Seibert, 1983), these regenerative interventions may have as 
main objectives, lateral, vertical or combined bone augmentation. 
Depending whether the implant could be placed with primary stability 
in the prosthetically driven position, these regenerative interventions 
could be simultaneous to the regenerative procedure or be staged to 
the implant installation (staged approach) (Benic & Hammerle, 2014; 
Hämmerle, Jung, & Feloutzis, 2002; Kuchler & von Arx, 2014; Merli 
et al., 2016).
While lateral augmentation procedures are highly predictable, with 
reported implant survival rates of 87%–95% and 99%–100% for the 
simultaneous and the staged approaches, respectively (Donos et al., 
2008), vertical ridge augmentation interventions have a low degree of 
predictability and a high incidence of complications (Rocchietta et al., 
2008). For lateral bone augmentation, two main approaches have 
been used, either using autogenous bone blocks fixated to the jaw 
bone by micro screws, or by means of guided bone regeneration (GBR) 
combining different bone replacement grafts and barrier membranes. 
A recent systematic review studied the efficacy of both types of in-
terventions in lateral bone augmentation (Sanz- Sanchez, Ortiz- Vigon, 
Sanz- Martin, Figuero, & Sanz, 2015). The results from the meta- 
analysis showed that for the simultaneous approach, the combination 
of bone replacement grafts and barrier membranes were associated 
with superior outcomes. For the staged approach, however, the com-
bination of bone blocks, particulated grafts and barrier membranes 
provided the best outcomes, although the morbidity and advent of 
postoperative complications when using this procedure should be 
taken into consideration.
Nowadays, with the better understanding on the ethiopathogen-
esis and the incidence of peri- implant diseases (Berglundh, Zitzmann, 
& Donati, 2011; Derks & Tomasi, 2015; Lang, Bosshardt, & Lulic, 
2011) and the low predictability in the treatment of peri- implantitis 
(Figuero, Graziani, Sanz, Herrera, & Sanz, 2014), it is important to 
assess the impact of the different implant surgical protocols on the 
peri- implant tissue health and the incidence of biological complica-
tions, at both short- and long- term. Whereas some cross- sectional 
retrospective studies have shown that implants placed into regener-
ated bone exhibit a clinical performance similar to implants placed into 
native bone with respect to implant survival, marginal bone height 
and peri- implant soft tissue parameters (Benic, Jung, Siegenthaler, & 
Hammerle, 2009; Zumstein, Billstrom, & Sennerby, 2012), there is not 
clear evidence on the possible effect of these bone augmentation pro-
cedures on the health of the peri- implant mucosa and on the incidence 
of peri- implantitis.
It is, therefore, the purpose of this systematic review to answer the 
following P.I.C.O. question: In patients with horizontal alveolar ridge 
deficiencies (population), what is the effect of lateral bone augmenta-
tion procedures (intervention and comparison) on peri- implant health 
(outcome)?
Additionally, we would like to answer the following question:
“What lateral bone augmentation procedures are associated with su-
perior short- and long-term outcomes associated with peri-implant 
health?”
2  | MATERIAL AND METHODS
2.1 | Protocol development and eligibility criteria
A protocol was developed and followed the PRISMA (Preferred 
Reporting Items for Systematic Review and Meta- Analyses) statement 
(Moher, Liberati, Tetzlaff, & Altman, 2009).
2.1.1 | Inclusion criteria (PICOS)
Population: patients, older than 18 years and in good general health, 
requiring the placement of one or more implants is sites presenting 
ridge deficiencies.
Interventions: any procedure aimed for lateral bone augmentation (si-
multaneous or staged).
Comparisons: any procedure aimed for lateral bone augmentation (si-
multaneous or staged) or the absence of treatment.
Outcomes: peri-implant health outcomes, such as peri-implant bleed-
ing index.
Study design: randomised controlled clinical trials (RCTs) or controlled 
clinical trials (CCTs) with a minimum sample size of 10 patients (five 
per group) and a minimum follow-up time of 12 months after im-
plant loading.
2.1.2 | Exclusion criteria
1. Studies assessing the effectiveness of interventions aimed at 
vertical bone augmentation (GBR, bone blocks, distraction os-
teogenesis, orthognathic surgery, inter-positional grafts, maxillary 
sinus augmentation, etc.).
2. Studies aimed at regenerating extractions sockets with or without 
implant placement.
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3. Preclinical studies in animal models.
4. Articles published in a different language than English.
2.1.3 | Type of interventions and comparisons
Studies were selected when including interventions aimed for lateral 
ridge augmentation with one of these objectives:
1. To locally augment the bone horizontally around an implant to 
cover exposed threads in dehiscence or fenestration type defects 
(simultaneous approach).
2. To locally augment the bone horizontally to enable the placement of 
a dental implant in a subsequent intervention (staged approach).
The following procedures were considered: (i) GBR; (ii) autogenous 
bone blocks; (iii) allogeneic or xenogeneic bone blocks; (iv) Ridge expan-
sion techniques.
2.1.4 | Types of outcomes
The primary outcomes to assess the peri- implant health status were 
the percentage of sites positive to bleeding on probing (BOP) at the 
end of the study. This outcome was calculated as the average of posi-
tive sites only around implants. In the studies where a different bleed-
ing index was used and when the raw data could be obtained, the 
results were transformed to positive or negative BOP.
The following secondary outcomes were studied:
1. Implant survival rates (%).
2. Probing pocket depth (PPD).
3. Interproximal crestal bone level changes assessed with periapical 
x-rays (mm).
4. Plaque indexes (PI).
5. Bone level changes assessed with a cone beam computer tomogra-
phy (CBCT).
6. Patient reported outcome measurements (PROMs), such as pain, 
discomfort, satisfaction, etc.
7. Occurrence of biological complications (%). Biological complica-
tions were defined as the occurrence of mucositis (BOP with or 
without increased PPD and without radiographic bone loss) and/or 
peri-implantitis (BOP with or without increased PPD and with ra-
diographic bone loss) (Lang & Berglundh, 2011).
2.1.5 | Search strategy
Three electronic databases were used as sources in the search for 
studies satisfying the inclusion criteria: (i) The National Library of 
Medicine (MEDLINE via Pubmed); (ii) Embase and (iii) Cochrane 
Central Register of Controlled Trials. These databases were searched 
for studies published until August 2016. The search was limited to 
humans, English language and articles reporting clinical trials.
All reference lists of the selected studies were checked for 
cross- references. The following journals were hand searched from 
year 2006 to 2016: Journal of Clinical Periodontology, Journal of 
Periodontology, Clinical Oral Implants Research, International Journal 
of Oral & Maxillofacial Implants, European Journal of Oral Implantology, 
Implant Dentistry, International Journal of Oral and Maxillofacial Surgery, 
Journal of Dental Implantology, Journal of Oral and Maxillofacial Surgery 
and Clinical Implant Dentistry and Related Research.
The following search terms were used:
Population
[text words]: “dental implant” OR “dental implants” OR “oral implant” OR 
“oral implants” OR “implant dehiscence” OR “implant dehiscences” OR 
“dehiscence defect” OR “dehiscence defects” OR “fenestration defect” OR 
“fenestration defects” OR “alveolar bone loss” OR “ridge atrophy” OR “ridge 
deficiency” OR “horizontal ridge deficiency” OR “alveolar ridge atrophy”
OR
[MeSH terms]: alveolar bone loss OR dental implants OR bone 
resorption
Intervention
[text words]: “bone augmentation” OR “lateral bone augmentation” 
OR “guided bone regeneration” OR GBR OR “alveolar ridge augmen-
tation” OR “lateral ridge augmentation” OR “bone regeneration”
OR
[MeSH terms]: bone regeneration OR guided tissue regeneration 
OR alveolar ridge augmentation OR alveolar bone grafting
Population AND Intervention
2.2 | Screening methods
Two reviewers (ISS and AC) did the primary search by screening inde-
pendently the titles and abstracts. The same reviewers selected for eval-
uation the full manuscript of those studies meeting the inclusion criteria, 
or those with insufficient data in the title and abstract to make a clear 
decision. Any disagreement was resolved by discussion with a third re-
viewer (MS). The inter- reviewer reliability (percentage of agreement and 
kappa correlation coefficient) of the screening method was calculated.
2.3 | Data extraction
One reviewer (ISS) extracted the data. Authors of studies were con-
tacted for clarification when data was incomplete or missing. Data were 
excluded until further clarification could be available if agreement could 
not be reached. When the results of a study were published more than 
once or if the results were presented in a number of publications, the 
data with longest follow- up was included only once. Information regard-
ing tobacco consumption and history of periodontitis was collected.
2.4 | Assessment of risk of bias
Quality of the included RCTs and CCTs was assessed by one reviewer 
(ISS), following the Cochrane Collaboration recommendations (Higgins 
& Green, 2011).
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The following items were evaluated as low, high or unclear risk of 
bias:
1. Selection bias (sequence generation and allocation concealment).
2. Performance bias (blinding of participants/personnel).
3. Detection bias (blinding of outcome assessment).
4. Attrition bias (incomplete outcome data).
5. Selective reporting bias (selective reporting outcomes).
6. Other potential risk of bias.
2.5 | Data synthesis
To summarise and compare studies, mean and standard devia-
tion (SD) values were directly pooled and analysed with weighted 
mean differences (WMDs) and 95% confidence intervals (CIs). For 
comparing the changes on BOP, two types of meta- analyses were 
performed. The first one compared the final and baseline visits 
within each arm of the RCT independently, whereas the second 
evaluated the differences on the changes over time among in-
terventions. This second meta- analysis was also applied to PPD, 
marginal bone loss and plaque. In the case of studies with more 
than two arms, each intervention was compared against the con-
trol group.
Study- specific estimates were pooled with both the fixed and 
random- effect models (DerSimonian & Laird 1986) and the random- 
effect model results were presented. The use of a particulate xeno-
graft and a collagen resorbable membrane was selected as the control 
group in most of the studies. In addition, two subgroup analyses were 
performed based on the type of procedure that was compared against 
the most common control group (particulate xenograft and collagen 
resorbable membrane) and the type of follow- up (short- term: up to 
3 years, long- term: ≥5 years).
The statistical heterogeneity among studies was assessed using 
the Q test, according to chi- square statistics and the I2 index (I2 = 25%: 
low; I2 = 50%: moderate; I2 = 75%: high heterogeneity).
The publication bias was evaluated using the Begg′s and Egger′s 
tests for small- study effects for BOP change. A sensitivity analysis of 
the meta- analysis results was also performed.
Forest plots were created to illustrate the effects of the differ-
ent studies and the global estimation in the meta- analysis. STATA® 
(StataCorp LP, Lakeway Drive, College Station, TX, USA) intercooled 
software was used to perform all analyses. Statistical significance was 
defined as a p- value < .05.
3  | RESULTS
3.1 | Search
Figure 1 depicts the study flow chart. Ten thousand and nine hundred 
and fifty- one titles were identified by the electronic search before ap-
plying the limits and 2,831 after. Once the titles and abstracts were 
evaluated, 2,661 articles were discarded, resulting in 170 studies, 
which after including 16 additional ones found on the manual search, 
resulted in 186 potentially relevant papers that were subjected to full 
text analysis (agreement = 86.15%; κ = .723; 95% CI [0.487; 0.894]). 
After this analysis, twelve final publications were included reporting 
data from eight different studies, as four publications reported long- 
term data from already included studies. The reasons for excluding of 
the remaining studies are reported in Appendix S2.
3.2 | Description of studies
Table 1 depicts the methodological characteristics of the selected 
studies. From the eight selected studies, six investigated the simulta-
neous approach (three parallel RCTs and three split- mouth RCTs) and 
two the staged approach (two parallel RCTs). Three groups of papers 
reported longer follow- ups from the same investigation (Schwarz, 
Hegewald, Sahm, & Becker, 2014; Schwarz, Schmucker, & Becker, 
2016 from Schwarz, Sahm, & Becker, 2012; Jung, Benic, Scherrer, & 
Hammerle, 2015 from Ramel, Wismeijer, Hammerle, & Jung, 2012; 
Meijndert et al., 2016 from Meijndert, Raghoebar, Meijer, & Vissink, 
2008). When data from more than one experimental or control group 
were reported, each comparison was considered independently 
(Amorfini, Migliorati, Signori, Silvestrini- Biavati, & Benedicenti, 2014; 
Meijndert et al., 2008, 2016). The two comparisons of these four- 
armed and three- armed studies appeared in the meta- analysis Forest 
plots with references a and b.
This systematic review pooled data from 256 systemically healthy 
patients at baseline (200 at the end of the study), with a total of 405 
implants placed. The mean follow- up period taking into consideration 
the longest evaluation from each investigation was of 50.25 months, 
with a minimum of 12 months (Amorfini et al., 2014; Van Assche, 
Michels, Naert, & Quirynen, 2013) and a maximum of 120 (Meijndert 
et al., 2016). Four of eight investigations reported on the tobacco con-
sumption, with two studies including non- smoker patients (Meijndert 
et al., 2016; Schwarz et al., 2016) and two additional specifying the 
number of smokers (one to three) per group (Jung et al., 2017; Van 
F IGURE  1 Flow- chart depicting the search strategy and selection 
process
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Assche et al., 2013). Periodontally healthy patients were recruited 
in two studies (Cordaro, Torsello, Morcavallo, & di Torresanto, 2011; 
Meijndert et al., 2016), whereas no information on the periodon-
tal diagnosis was given in the remaining articles. When stratified by 
treatment group, 141 patients were treated with the simultaneous 
approach (106 completed the follow- up) and 115 patients with the 
staged approach (94 completed the follow- up). No single study was 
identified matching the inclusion criteria for the ridge expansion ap-
proach. The most common regenerative intervention was the use of 
a particulated xenogeneic bone replacement graft (de- proteinized 
bovine bone mineral DBBM) combined with a bioabsorbable native 
collagen barrier membrane, which was considered the control group in 
six of eight from the investigations included in the systematic review 
(Amorfini et al., 2014 [C: 2]; Jung et al., 2009, 2015, 2017; Meijndert 
et al., 2016; Schwarz et al., 2016).
3.3 | Assessment of risk of bias
Table 2 depicts the risk of bias for RCTs. Only three publications 
showed a low- risk of bias in all the fields (Jung et al., 2017; Schwarz 
et al., 2014, 2016) and one in all except for one (Jung et al., 2015). In 
general, most of the RCTs showed a low- risk of bias in the majority of 
the categories.
No publication bias for BOP changes was detected by Begg 
(p = .851) or Egger tests (p = .663). The sensitivity analyses for this 
outcome showed that the exclusion of a single study did not substan-
tially alter any estimate.
3.4 | Effects of interventions
3.4.1 | Main outcome: Inflammation of the Peri- 
implant Mucosa
In case of incomplete data, the authors were contacted and the 
bleeding or gingival indexes could be transformed to BOP values. 
One investigation was not included in the meta- analysis as only 
the final values were reported (Cordaro et al., 2011). The longest 
follow- up from the same study was included in the meta- analysis. 
Changes in BOP percentages for all treatment modalities were not 
significant when comparing test to control treatment protocols 
(n = 6; weighted mean difference [WMD] = −3.36; 95% CI [−12.49; 
5.77]; p < .471) and there was a low heterogeneity (I2 = 0%; 
p = .891). Additionaly, no significant differences could be observed 
between groups when comparing the use of a xenograft plus a na-
tive collagen membrane to different types of membranes, to the 
addition of biological factors, such as bone morphogentic proteins 
(BMP’s) or recombinant human platelet- derived growth factor- BB 
(rh PDGF- BB). Similarly, the use of autogenous bone blocks plus bi-
oabsorbable collagen membrane resulted in similar outcomes when 
compared to the use of the bone block alone (Table 3) (Figure 2). 
When evaluating the differences between groups depending on the 
follow- up (1–3 years or >3 years), no significant differences were 
detected (Table 3) (Figure 3).
A meta- analysis was conducted to evaluate the changes on BOP 
values within each treatment modality (final minus baseline). For the 
overall procedures, there was no significant change over time (n = 10; 
WMD = −10.02; 95% CI [−22.23; 2.20]; p = .108) and there was a 
medium heterogeneity (i2 = 59.3%; p < .009). When evaluating each 
treatment modality independently, there was a statistically significant 
reduction in BOP values when a cross- linked membrane plus a par-
ticulate xenograft was used (n = 1; WMD = −41.6; 95% CI [−63.51; 
−19.68]; p < .001). Some procedures were excluded from this meta- 
analyses due to an imputed weight of 0% (Particulate xenograft + col-
lagen membrane [n = 2], rhPDGF- BB+ particulate xenograft + collagen 
membrane [n = 1], chin blocks [n = 1], spontaneous healing [dehis-
cence] [n = 1]; allografts blocks + collagen membrane + rhPDGF- BB 
[n = 1], allograft blocks + collagen membrane [n = 1]) (Table 4).
3.4.2 | Effects of interventions: Secondary outcomes
Data on implant survival was provided in all the studies except two 
(Schwarz et al. 2014, 2016). The mean implant survival rate was 
99.24% (min: 93.5%; max: 100%), and there were no differences be-
tween the test and control groups (98.56% and 100%, respectively).
Data on PPD were reported in all the studies except one (Ramel 
et al., 2012). Two additional studies only reported the final values, so 
they were not included in the meta- analysis (Cordaro et al., 2011; Jung 
et al., 2015) and a total of six investigations were considered. The re-
sults revealed no significant differences between the test and control 
groups neither for the overall analysis (n = 6; WMD = −0.051; 95% 
[−0.333; 0.232]; p = .726) nor for any of the comparisons between 
xenograft plus a native collagen membrane and different membranes, 
biological factors (BMP’s, PDGF), bone blocks or the spontaneous 
healing of the dehiscence. When evaluating the results depending on 
the follow- up, no significant differences were observed (Table 5).
Radiographic changes in crestal bone levels were assessed in all the 
investigations except two (Cordaro et al., 2011; Schwarz et al., 2016), 
both as mesial and distal values, or as its average. The meta- analysis 
revealed no significant differences between the test and control treat-
ment approaches when compared all together (n = 6; WMD = 0.062; 
95% CI [−0.130; 0.253]; p = .527). The only significant differences 
were observed in the study in which a xenograft plus a native collagen 
membrane was compared to the spontaneous healing in the treatment 
of dehiscence defects, with a statistical significant greater amount of 
bone loss for the group with no treatment (n = 1; WMD = 0.41; 95% 
CI [0.003; 0.817]; p = .048) (Table 5).
Plaque accumulation was evaluated in all the investigations except 
two (Cordaro et al., 2011; Van Assche et al., 2013). The meta- analysis 
revealed no significant differences between the test and treatment 
approaches for plaque changes over time (n = 6; WMD = −5.12; 95% 
CI [−15.54; 5.31]; p = .337). The only significant difference when 
evaluating the type of comparison or the follow- up was observed 
for the group using autogenous bone blocks, with a statistically sig-
nificant greater reduction in plaque levels compared to the group 
using particulate xenografts plus a native collagen membrane (n = 1; 
WMD = −28.81; 95% CI [−56.25; −1.37]; p = .04) (Table 5).
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Bone level changes assessed with a CBCT were monitored in two 
studies. In one investigation, the defect height reduction at the buccal 
aspect was evaluated at baseline and 5 years with similar results when 
comparing two types of membranes (Jung et al., 2015). Additionally, 
the buccal bone width at different apico- coronal levels and the dis-
tance between the mucosal margin and the implant shoulder were 
assessed. In another study, the bone volume changes (cm3) were 
compared between the baseline preoperative situation and the 1 year 
follow- up, with similar changes when comparing the GBR procedure 
to the use of an allograft block, although there was higher bone re-
sorption when the blocks were immersed in saline compared to those 
immersed in rh PDGF- BB (Amorfini et al., 2014).
F IGURE  2 Forest- plots for the bleeding on probing meta- analysis for studies comparing particulate xenograft (DBBM) and collagen 
resorbable membrane as control groups compared to different interventions: type of intervention
TABLE  3 Meta- analyses on the change between final and baseline values of BOP the studies comparing particulate xenograft (DBBM) and 
collagen resorbable membrane as control groups compared to different interventions: test vs. control
Index Subgroup n
Weighted mean difference Heterogeneity
DL
95% CI
p- Value I2 (%) p- ValueUpper Lower
BOP change All 6 −3.362 −12.495 5.771 .471 0 .891
Type of comparison Membrane (PEG; 
cross- linked)
2 −8.393 −27.468 10.683 .389 0 .453
BMPs, PDGF 1 −0.610 −44.191 42.971 .978
Spontaneous healing 1 −1.000 −14.044 12.044 .881
Chin bone+resorbable 
membrane
1 3.940 22.160 30.040 .767
Chin bone 1 −12.290 −39.313 14.733 .373
Follow- up ≥5 years 5 −5.634 −18.425 7.157 .388 0 .836
Up to 3 years 1 −1.000 −14.044 12.044 .881
BMP, bone morphogentic proteins; BOP, bleeding on probing; PDGF, platelet- derived growth factor.
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F IGURE  3 Forest- plots for the bleeding on probing meta- analysis for studies comparing particulate xenograft (DBBM) and collagen 
resorbable membrane as control groups compared to different interventions: follow- up
TABLE  4 Meta- analysis on the increment on BOP values when comparing final- baseline data: final vs. baseline
Subgroup n
WMD Heterogeneity
DL
95% CI
p- Value I2 (%) p- ValueUpper Lower
All 10 −10.016 −22.232 2.200 .108 59.3 .009
 Particulate xenograft + PGE 
membrane
1 19.790 −8.893 48.473 .176
Procedure
 Particulate xenograft + cross- link 
membrane
1 −41.600 −63.515 −19.685 <.001
 rh_BMP2 + particulate xeno-
graft + collagen membrane
1 11.970 −31.365 55.305 .588
 Chin blocks + collagen membrane 1 −19.490 −41.617 2.637 .084
 Particulate autologous bone + 
particulate HA (60%)_TCP (40%) 
bone+ collagen membrane
1 −14.000 −31.038 3.038 .107
 Particulate xenograft + collagen 
membrane
4 −6.729 −31.269 17.810 .591 63.4 .042
 Particulate xenograft + particulate 
autologous bone + collagen 
membrane
1 −7.000 −22.191 8.191 .366
BMP, bone morphogentic proteins; BOP, bleeding on probing; PDGF, platelet- derived growth factor; WMD, weighted mean difference.
WMD represents the change on BOP between final and baseline visit. Negative symbol means a reduction in BOP values over time. Positive symbol means 
an increment in BOP values over time. Some procedures were excluded from the meta- analyses due to an imputed weight of 0% (Particulate xeno-
graft + collagen membrane [n = 2] rhPDGF- BB+ particulate xenograft + collagen membrane [n = 1], chin blocks [n = 1], spontaneous healing [dehiscence] 
[n = 1]; allografts blocks + collagen membrane + rhPDGF- BB [n = 1], allograft blocks + collagen membrane [n = 1]).
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PROMs were evaluated in two studies. In one of them patients were 
asked to grade the condition of their gums and their ability for a proper 
hygiene using a visual analogue scale (Jung et al., 2009). In the other, 
the overall patient satisfaction, and specifically in relation to the final 
restoration, the peri- implant tissues and the overall percentage of ac-
ceptable results were recorded (Meijndert et al., 2016). For none of the 
comparisons, significant differences were detected between groups.
The occurrence of biological complications based on case defini-
tions was only reported in one investigation including three articles 
(Schwarz et al., 2012, 2014, 2016). After 6–8 years of follow- up, the in-
cidence of peri- implant mucositis varied from 37% to 47% and for peri- 
implantitis from 16% to 26%, without significant differences between 
groups. Additionally, two studies reported the percentage of cases with 
bone loss ≥1.5–2 mm (Ramel et al., 2012; Van Assche et al., 2013) and 
four studies reported co- existence of healthy peri- implant tissues with 
minimal bone loss (Amorfini et al., 2014; Cordaro et al., 2011; Jung 
et al., 2009, 2017). In one study implants had to be extracted due to 
buccal bone resorption with altered aesthetics (Meijndert et al., 2016).
4  | DISCUSSION
Based on 12 publications reporting data from eight different inves-
tigations, the results from this systematic review indicated that the 
TABLE  5 Meta- analyses on the change between final and baseline values of PPD, PI and bone loss on the studies comparing particulate 
xenograft (DBBM) and collagen resorbable membrane as control groups compared to different interventions: test vs. control
Index Subgroup n
Weighted mean difference Heterogeneity
DL
95% CI
p- Value I2 (%) p- ValueUpper Lower
PPD change All 6 −0.051 0 0 .726 0 .71
Type of comparison Membrane (PGE. 
cross- linked)
1 0 −0.547 0.547 1
BMPs/PDGF 2 0.109 −0.33 0.547 .626 0 .732
Spontaneous healing 1 0.17 −0.797 1.137 .73
Chin bone+resorbable 
membrane
1 −0.54 −1.377 0.297 .206
Chin bone 1 −0.42 −1.251 0.411 .322
Follow- up ≥5 years 4 −0.151 −0.522 0.219 .423 0 .528
Up to 3 years 2 0.091 −0.348 0.529 .685 0 .857
Bone loss All 6 0.062 0 .527 19.8 .284
Type of comparison Membrane (PGE. 
cross- linked)
1 0.11 −0.269 0.489 .57
BMPs/PDGF 2 −0.04 −0.328 0.248 .785 44.5 .18
Spontaneous healing 1 0.41 0.003 0.817 .048
Chin bone+resorbable 
membrane
1 −0.13 −1.141 0.881 .801
Chin bone 1 −0.02 −1.008 0.968 .968
Follow- up ≥5 years 4 0.102 −0.144 0.347 .417 0 .959
Up to 3 years 2 0.101 −0.455 0.658 .722 81.8 .019
Plaque change All 6 −5.122 −15.538 5.314 .337 11.7 .34
Type of comparison Membrane (PGE. 
cross- linked)
1 8.28 −10.694 27.254 .392
BMPs/PDGF 2 0.524 −23.092 24.141 .965 0 .936
Spontaneous healing 1 −11.01 −27.105 5.085 .18
Chin bone+resorbable 
membrane
1 0.47 −28.592 29.532 .975
Chin bone 1 −28.81 −56.247 −1.373 .04
Follow- up ≥5 years 4 −4.059 −21.23 13.112 .643 37.8 .185
Up to 3 years 2 −8.306 −22.523 5.912 .252 0 .482
BMP, bone morphogentic proteins; PDGF, platelet- derived growth factor;PI, Plaque indexes; PPD, probing pocket depth.
The bold p-value means a statistical significant difference
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interventions aimed for lateral bone augmentation and the different 
combinations of bone replacement grafts and barrier membranes 
could maintain stable results over time in terms of peri- implant mu-
cosal inflammation and maintenance of crestal bone levels. When 
evaluating each treatment approach independently, the meta- analysis 
showed that these interventions resulted in low BOP values over time, 
without significant differences among interventions. When evaluating 
other peri- implant health outcomes, such as marginal bone level, PPD 
and plaque level changes, similar results were reported among the dif-
ferent surgical interventions, both at short- (up to 3 years) and long- 
term (≥5 years) follow- ups.
These results are in agreement with long- term studies in which 
implants receiving GBR procedures have been compared to implants 
placed in native bone without any augmentation (Benic et al., 2009; 
Jung, Fenner, Hammerle, & Zitzmann, 2013). As it is impossible to 
randomise which implant is going or not to receive bone augmenta-
tion, cohort studies are needed to compare both treatment modal-
ities. In a recent publication (Benic, Bernasconi, Jung, & Hammerle, 
2017), machined implants receiving simultaneous bone regeneration 
with a particulate xenograft or autologous bone plus, a native colla-
gen membrane were compared to standard implant placement without 
GBR. At 15 years, interproximal marginal bone levels (MBL) averaged 
1.44 ± 0.84 mm for the GBR group and 1.69 ± 0.84 mm for the con-
trol group and from the 5- to the 15- year examination, the loss of 
interproximal MBL averaged 0.23 ± 0.70 mm for the GBR group and 
0.28 ± 0.63 mm for the control group. Similarly, no significant differ-
ences were observed for BOP (46.2 ± 27.7 GBR vs. 38.3 ± 28.8 con-
trol), plaque scores (36.3 ± 30.7 GBR vs. 30.4 ± 36.2 control) or PPD 
(3.12 ± 0.71 GBR vs. 3.05 ± 0.67 control).
One criticism to all these studies assessing the long- term outcome 
of horizontal bone regeneration is the fact that crestal bone levels 
were mainly assessed through conventional periapical radiography, 
which only evaluates by dimensionally mesial and distal sites, instead 
of buccal sites, which is precisely the area where bone augmentation 
was carried out. Although three- dimensional tomography is available 
for evaluating the outcome of regenerated bone, the resulting higher 
radiation burden does not justify this evaluation, as there is no direct 
benefit to the patient (Harris et al., 2012).
At the eighth European Workshop of Periodontology (EWP), the 
occurrence of biological complications was identified as a main out-
come domain when evaluating the long- term efficacy of implant ther-
apy (Tonetti & Palmer, 2012). Identification of peri- implant diseases 
has been hampered by the use of diverse diagnostic criteria and case 
definitions (Tomasi & Derks, 2012). The following case definitions 
were recommended for peri- implant mucositis and peri- implantitis 
at a European Workshop (Sanz and Chapple (2012). For prevalence 
studies, in the absence of baseline radiographs, a bone level of 2 mm 
from the expected level together with clinical inflammation was 
set as a threshold to define peri- implantitis in the presence of peri- 
implant mucosal inflammation. For incidence studies with existing 
baseline radiological measures, a bone loss of 1–1.5 mm in combi-
nation with inflammation was established as the minimum threshold. 
In this systematic review, however, only one investigation use well 
established case definitions for peri- implant diseases (Schwarz et al., 
2012, 2014, 2016) and in two other studies, only those cases with 
bone loss ≥1.5–2 mm was diagnosed (Ramel et al., 2012; Van Assche 
et al., 2013). Another difficulty when analysing the data was that 
each investigation considered a different time point for the baseline 
evaluation. It was, therefore, impossible to homogenise the data and 
to obtain a clear conclusion in regards to the change in peri- implant 
health over time.
To answer the question “Which hard tissue augmentation proce-
dures better maintain peri- implant health?” the results from this sys-
tematic review clearly demonstrated that there were no differences 
between the assessed treatment modalities. A previous systematic 
review reported on the effectiveness of the interventions aimed for 
lateral ridge augmentation and the most suitable biomaterials used 
as bone replacement grafts and barrier membranes (Sanz- Sanchez 
et al., 2015). It was shown that the type of membrane or bone graft 
could have a significant impact on the outcome of the regeneration 
(peri- implant defect height reduction). This systematic review did not 
study the possible influence of the different interventions on the peri- 
implant tissue health. It was interesting that the use of a particulate 
xenograft (DBBM) plus a native collagen membrane was selected in 
six of eight investigations as the standard of care or positive control 
for studying new regenerative interventions aiming for horizontal 
bone augmentation. The comparisons resulted in similar outcomes in 
regards to peri- implant health, irrespective of the addition of biolog-
ical factors or different absorbable membranes or bone replacement 
grafts.
The lack of differences in some of the comparisons analysed may 
be due to the questioned reliability of periodontal parameters to as-
sess peri- implant health (Coli, Christiaens, Sennerby, & Bruyn, 2017). 
BOP was selected as the primary outcome to be compliant with the 
conclusions from the seventh European Workshop on Periodontology, 
where it was agreed that inflammation disclosed by BOP was the most 
objective parameter to assess peri- implant tissue inflammation (mu-
cositis) and the combination of BOP and bone loss the two key pa-
rameters in the case definition for peri- implantitis (Lang & Berglundh, 
2011). However, it is important to bear in mind that BOP is a poor pre-
dictor of peri- implant health, while its absence is a much more valuable 
indicator (Coli et al., 2017). Furthermore, the dichotomous nature of 
BOP makes it very challenging to ascertain the correlation that it may 
have with disease status and severity. It has been shown that several 
factors such as gender or implant position can influence BOP values 
around implants (Farina, Filippi, Brazzioli, Tomasi, & Trombelli, 2017). 
Moreover, excessive probing forces may induce false positive BOP 
readings (Gerber, Tan, Balmer, Salvi, & Lang, 2009). Additionally, the 
access to insert the periodontal probe in cases of overhanging resto-
rations may underestimate PPD values (Serino, Turri, & Lang, 2013) 
and may induce trauma in the soft tissues, increasing false positive 
BOP.
To answer the question “are these horizontal bone augmentation 
procedures justified?” the present systematic review only found one 
RCT aimed to study whether to treat or not small dehiscence type 
defects (≤5 mm) (Jung et al., 2017). After 18 months of follow- up, it 
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was demonstrated that although both groups had similar values for 
BOP, PPD and plaque levels, therefore compatible with peri- implant 
health, dehiscence defects without regenerative treatment expe-
rienced significant greater crestal bone loss (mean: 0.41 mm; 95% 
CI: 0.003–0.817). It has also been suggested that residual defect 
areas with exposed implant rough surfaces may be at a higher risk of 
accumulating bacterial biofilms and subsequently developing peri- 
implant diseases, although there are no prospective cohort studies 
available to answer this question. Indirect evidence comes from a 
cross- sectional study studying the impact of the residual dehiscence 
defects on the development of peri- implant diseases 4 years after 
lateral bone regeneration procedures comparing two absorbable 
membranes (Schwarz et al., 2012). It was concluded that implants 
exhibiting residual defect height values >1 mm were at higher risk 
of developing peri- implant diseases and these residual defects might 
be associated with increased mucosal recession, which may com-
promise the aesthetic outcomes. Based on these data it does not 
seem reasonable to leave exposed implant surfaces without further 
treatment.
The fact that most of the selected studies from this systematic 
review have shown good results in terms of the maintenance of peri- 
implant health may be explained by the ideal circumstances in which 
these studies have been performed. In most of the cases, the patients 
were followed closely and if inflammation was detected, prompt treat-
ment was carried out. Despite our efforts to study the impact of lat-
eral bone augmentation in peri- implant health or disease, very few 
investigations have evaluated the incidence of peri- implant disease. 
Although the onset of peri- implantitis has been reported to occur 
as soon as 3 years after loading (Derks et al., 2016), there is a need 
of longer follow- up evaluations, as the shift from mucositis to peri- 
implantitis requires the detection of early signs of bone loss, which 
demands a long- term longitudinal evaluation.
When evaluating peri- implant health or disease is important to 
bear in mind that different factors can contribute to an increase risk 
for mucosal inflammation, such as residual increased PPD in the re-
maining dentition, smoking, implant position, access to oral hygiene, 
excess of cement or the type of prosthetic rehabilitation (Jepsen et al., 
2015).
This systematic review has some limitations. First of all, the lim-
ited number of included studies in the meta- analyses. This was evident 
with BOP data, as several studies had to be excluded from the anlyses 
and therefore, no subgroup analysis could be performed for the con-
founding factors (tobacco consumption and periodontal diagnosis) or 
the level of analysis (implant or patient level). This fact determined 
that implant level and patient level data were pooled together in the 
meta- analysis, which might underestimate the CIs for the pooled es-
timate, hence rising the type- I error. Despite our efforts to perform 
a meta- analysis for all the variables evaluated, we could not do it for 
either the biological complications or the PROMs due to the scarcity of 
studies reporting these outcomes. Another limitation was due to the 
fact that the included studies were not primarily designed to detect 
differences on peri- implant health (gingival or bleeding index) indices. 
Due to these limitations, care should be applied when interpreting the 
results, as the included data were probably not powered for the ana-
lysed outcomes.
The decision to limit the search to controlled studies written in 
English and to dismiss the case series, cohort studies or the grey 
literature may have induced a high- risk of misrepresentation of the 
pertinent evidence, as the amount of potentially relevant articles 
that were automatically excluded could be high. In accordance with 
PRISMA guidelines, the protocol development of the PICO question 
were strictly followed. Furthermore, due to the limited number of con-
trolled studies, we aimed to be inclusive and we established a very low 
threshold on subjects per group.
The results from this systematic review and meta- analysis have 
shown that lateral ridge augmentation procedures are associated with 
a high implant survival rate and adequate peri- implant health over 
time with small changes on BOP values and a low incidence of cases 
presenting peri- implant bone loss.
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